🇺🇸 FDA
Patent

US 10723741

DNA polymerase IIIC inhibitors and use thereof

granted A61KA61K31/519A61P

Quick answer

US patent 10723741 (DNA polymerase IIIC inhibitors and use thereof) held by Acurx Pharmaceuticals, Inc. expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/519, A61P, A61P31/04